YNL324W is a gene encoding a protein of unknown molecular function in S. cerevisiae. Key genomic and proteomic features include:
Protein Properties: Derived from laboratory strain S288c; sequence details, molecular weight, and isoelectric point are available via the Saccharomyces Genome Database (SGD) .
Phenotypic Data: Limited curated mutant allele or interaction data exists for YNL324W, suggesting it is understudied .
The YNL324W Antibody has been utilized in:
Protein Identification: Validated for antigen detection in ELISA and WB .
Chromatin Studies: Indirect evidence suggests its use in chromatin immunoprecipitation (ChIP) assays to study histone variant Htz1 localization, though direct citations are sparse .
Genetic Suppression Networks: While not directly linked to YNL324W, genome-wide screens in yeast have identified dosage suppressors of temperature-sensitive mutants, highlighting the broader context of yeast genetic research .
Specificity: Reactivity is restricted to S. cerevisiae strains expressing the YNL324W protein. Cross-reactivity with other species has not been reported .
Functional Insights: The biological role of YNL324W remains uncharacterized, limiting interpretability of antibody-based findings .
Storage Stability: Requires strict adherence to storage protocols to prevent degradation .
While YNL324W itself is not directly implicated in disease, studies on monoclonal antibodies (e.g., anti-Ebola or anti-HIV therapies) underscore the importance of antibody validation and functional characterization in translational research . These parallels emphasize rigorous testing for research antibodies like YNL324W to ensure reproducibility.
STRING: 4932.YNL324W
YNL324W is a protein found in Saccharomyces cerevisiae (Baker's yeast), specifically identified in strain 204508/S288c. The protein has been studied as part of functional genomics approaches to understand fundamental yeast biology and protein function . While the specific cellular functions of YNL324W are still being investigated, antibodies against this protein serve as valuable tools for researchers studying yeast genetics, protein interactions, and cellular processes.
The study of yeast proteins like YNL324W contributes significantly to our understanding of eukaryotic cell biology, as many fundamental cellular processes are conserved across species. Antibodies that specifically recognize YNL324W enable researchers to track its expression, localization, and interactions under various experimental conditions.
Based on the available information, polyclonal antibodies raised in rabbits against recombinant YNL324W protein are currently the primary type available for research . These antibodies are typically generated by immunizing rabbits with purified recombinant Saccharomyces cerevisiae YNL324W protein from strain 204508/S288c.
The commercially available antibodies are generally supplied in liquid form with preservation components including 0.03% Proclin 300, 50% Glycerol, and 0.01M PBS at pH 7.4 . This formulation helps maintain antibody stability and activity during storage and repeated use. The polyclonal nature of these antibodies means they recognize multiple epitopes on the YNL324W protein, which can be advantageous for detection in various experimental contexts.
According to available data, anti-YNL324W antibodies have been validated primarily for:
These applications represent the core techniques for detecting and quantifying YNL324W protein in experimental systems. In Western blot applications, the antibodies can detect the native YNL324W protein following separation by SDS-PAGE and transfer to a membrane. For ELISA applications, the antibodies can be used to detect and quantify YNL324W in solution, allowing for precise measurement of protein concentration in various samples.
While not explicitly validated in the provided search results, these antibodies may potentially be useful in other immunological techniques such as immunoprecipitation, immunohistochemistry, and immunofluorescence, though additional validation would be required for these applications.
For optimal antibody performance and longevity, researchers should follow these storage and handling recommendations:
Store antibodies at -20°C or -80°C upon receipt to maintain activity
Avoid repeated freeze-thaw cycles which can degrade antibody function
If necessary, briefly centrifuge vials to collect liquid that may become entrapped in the vial cap during shipping or storage
When working with the antibody, aliquoting the stock solution into smaller volumes for single-use can help prevent degradation from repeated freeze-thaw cycles. Always handle antibodies using appropriate laboratory techniques to prevent contamination and maintain sterility.
Rigorous validation of antibody specificity is essential for reliable research outcomes. For YNL324W antibodies, consider implementing these methodological approaches:
Genetic controls: Test the antibody in wild-type yeast expressing YNL324W alongside a knockout strain (ynl324wΔ) to confirm antibody specificity. The absence of signal in the knockout strain would strongly support antibody specificity.
Peptide competition assays: Pre-incubate the antibody with purified recombinant YNL324W protein before application in your detection method. Specific binding should be significantly reduced or eliminated if the antibody is truly specific.
Orthogonal detection methods: Confirm your findings using multiple techniques (e.g., Western blot, immunofluorescence, and mass spectrometry) to ensure consistent detection of the target protein.
Epitope tagging validation: Express YNL324W with an epitope tag (e.g., FLAG, HA) and perform parallel detection with both anti-YNL324W and anti-tag antibodies. Co-localization of signals would support specificity.
Mass spectrometry verification: Perform immunoprecipitation with the YNL324W antibody followed by mass spectrometry analysis to confirm the identity of the pulled-down proteins.
These validation strategies provide complementary evidence for antibody specificity and help ensure that experimental observations genuinely reflect YNL324W biology rather than artifacts from cross-reactivity.
For optimal Western blot results with YNL324W antibodies, consider the following methodological parameters:
| Parameter | Recommended Conditions | Optimization Notes |
|---|---|---|
| Sample preparation | Yeast cell lysis with glass beads or enzymatic method | Include protease inhibitors to prevent degradation |
| Protein amount | 20-50 μg total protein per lane | Adjust based on expression level |
| Separation | 10-12% SDS-PAGE | Modify based on YNL324W molecular weight |
| Transfer | PVDF or nitrocellulose membrane, semi-dry or wet transfer | Optimize transfer time based on protein size |
| Blocking | 5% non-fat dry milk or BSA in TBST, 1 hour at room temperature | Test both to determine optimal background reduction |
| Primary antibody | 1:500 to 1:2000 dilution, overnight at 4°C | Titrate to determine optimal concentration |
| Secondary antibody | Anti-rabbit HRP conjugate, 1:5000, 1 hour at room temperature | Ensure compatibility with detection system |
| Detection method | Enhanced chemiluminescence (ECL) | Adjust exposure time based on signal strength |
Systematically optimizing these parameters will help achieve clear, specific detection of YNL324W protein in Western blot applications. Include appropriate positive and negative controls in each experiment to validate results.
Yeast surface display represents a powerful platform for studying protein interactions and can be effectively integrated with YNL324W antibody applications:
Surface display construction: YNL324W can be expressed on the yeast cell surface as a fusion with the Aga2p protein, which naturally associates with the cell wall-anchored Aga1p protein . This system allows for the presentation of YNL324W in its native conformation while maintaining accessibility for interaction studies.
Enhanced reporter systems: Recent advances in yeast display technology have introduced improved reporter proteins such as eUnaG2 and DnbALFA, which can be co-expressed with YNL324W to monitor expression levels and surface localization . These reporter systems offer advantages in terms of brightness, stability, and ease of detection.
Flow cytometry analysis: Surface-displayed YNL324W can be detected using anti-YNL324W antibodies coupled with fluorescently-labeled secondary antibodies, enabling quantitative analysis by flow cytometry. This approach allows for:
Measurement of expression levels
Isolation of high-expressing clones
Quantification of binding interactions with potential partner proteins
Microscopy validation: Fluorescence microscopy can be used to confirm proper surface localization of YNL324W and distinguish it from proteins retained in the endoplasmic reticulum or other intracellular compartments . This validation step helps prevent false-positive results from improperly trafficked proteins.
This integrated approach combines the advantages of yeast display technology with the specificity of anti-YNL324W antibodies, enabling advanced studies of protein-protein interactions, epitope mapping, and protein engineering applications.
Researchers working with YNL324W antibodies may encounter several technical challenges. The following table outlines common issues and effective troubleshooting strategies:
| Problem | Possible Causes | Solutions |
|---|---|---|
| High background signal | Insufficient blocking, antibody concentration too high, inadequate washing | Increase blocking time, dilute antibody further, add additional wash steps, try different blocking agents |
| Weak or no signal | Low protein expression, inefficient transfer, epitope masking, degraded antibody | Increase protein loading, optimize transfer conditions, try different sample preparation methods, use fresh antibody |
| Multiple bands | Protein degradation, cross-reactivity, post-translational modifications | Add protease inhibitors, increase antibody specificity through optimization, verify with alternative methods |
| Inconsistent results | Protocol variations, antibody lot differences, sample preparation inconsistencies | Standardize protocols, use consistent antibody lots, prepare larger batches of working solutions |
| Non-specific binding | Insufficient blocking, high antibody concentration | Optimize blocking conditions, increase antibody dilution, pre-absorb antibody with yeast lysate lacking YNL324W |
Systematic troubleshooting using these approaches can help resolve technical issues and improve the reliability of experimental results when working with YNL324W antibodies.
Proper analysis and interpretation of data from YNL324W antibody experiments require careful consideration of several factors:
Quantification methods:
For Western blots: Use appropriate software for densitometric analysis, normalizing to loading controls such as actin or GAPDH
For ELISA: Generate standard curves using purified recombinant YNL324W protein for accurate quantification
For flow cytometry: Apply appropriate gating strategies and compensate for spectral overlap
Statistical analysis:
Perform experiments with sufficient biological and technical replicates (minimum n=3)
Apply appropriate statistical tests based on data distribution (parametric or non-parametric)
Report p-values and confidence intervals to indicate statistical significance
Data visualization:
Present Western blot images alongside quantification graphs
Use consistent scales and axes when comparing different conditions
Include error bars representing standard deviation or standard error
Controls interpretation:
Positive controls establish the detection system is working properly
Negative controls (such as ynl324wΔ strains) confirm antibody specificity
Loading controls ensure equal sample loading across comparisons
Integration with other data types:
Correlate protein expression data with transcriptomic data when available
Consider potential post-translational modifications when interpreting multiple bands
Place findings in the context of known protein interaction networks
The integration of CRISPR-Cas9 technology with YNL324W antibody applications offers powerful approaches for functional genomics studies:
Epitope tagging strategies:
Use CRISPR-Cas9 to introduce epitope tags (HA, FLAG, GFP) at the C- or N-terminus of endogenous YNL324W
This enables detection with well-characterized commercial antibodies alongside anti-YNL324W antibodies
Allows for multicolor imaging and co-localization studies
Domain-specific modifications:
Introduce precise mutations or deletions in specific domains of YNL324W using CRISPR-Cas9
Use anti-YNL324W antibodies to analyze how these modifications affect protein expression, stability, localization, and interactions
Generate domain-specific insights into protein function
Regulatory element editing:
Modify promoter or terminator regions of YNL324W using CRISPR-Cas9
Monitor resulting changes in expression levels using quantitative antibody-based methods
Gain insights into transcriptional and post-transcriptional regulation
Combinatorial genomic studies:
Generate combinatorial mutants affecting YNL324W and interacting partners
Use antibody detection to analyze genetic interactions and pathway connections
Identify synthetic lethal or synthetic rescue interactions
This integrated approach leverages the precision of CRISPR-Cas9 genome editing with the detection capabilities of antibodies to provide comprehensive insights into YNL324W function in cellular contexts.
Investigating post-translational modifications (PTMs) of YNL324W requires specialized approaches combining antibody detection with biochemical techniques:
PTM-specific detection strategies:
Use phospho-specific antibodies if phosphorylation sites on YNL324W have been characterized
Employ general PTM detection methods (anti-phospho, anti-ubiquitin, anti-SUMO antibodies) followed by YNL324W immunoprecipitation
Apply specific enzymatic treatments (phosphatases, deubiquitinases) to confirm PTM identity
Mass spectrometry approaches:
Immunoprecipitate YNL324W using validated antibodies
Analyze by mass spectrometry to identify and map specific modification sites
Quantify changes in modification levels under different conditions
2D gel electrophoresis:
Separate proteins based on both isoelectric point and molecular weight
Detect YNL324W using antibodies to identify multiple isoforms resulting from PTMs
Compare patterns under different cellular conditions
In vivo modification analysis:
Create reporter systems where YNL324W is fused to split fluorescent proteins that respond to specific modifications
Use anti-YNL324W antibodies to validate the reporter system findings
Monitor dynamic changes in modifications under various cellular conditions
These complementary approaches provide a comprehensive view of YNL324W post-translational modifications and their functional significance in cellular processes.